Related Experiment Video

Updated: May 18, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Growth parameters in children with dyspepsia symptoms and Helicobacter pylori infection

Seyed Mohsen Dehghani1, Hamdollah Karamifar, Tayebbeh Raeesi

  • 1Department of Pediatric Gastroenterology, and Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. dehghanism@sums.ac.ir

Indian Pediatrics
|October 2, 2012
PubMed

Insights

Helicobacter pylori infection in children with dyspepsia showed no significant link to growth retardation. This study found no meaningful relationship between H. pylori and standard deviation scores for height and BMI.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Child Health

Background:

  • Helicobacter pylori (H. pylori) infection is common in children.
  • A potential association between H. pylori and impaired somatic growth in children has been debated.
  • Understanding this relationship is crucial for pediatric health management.

Purpose of the Study:

  • To investigate the association between H. pylori infection and growth parameters in children.
  • To determine if H. pylori status correlates with height, weight, or BMI standard deviation scores.
  • To clarify the impact of H. pylori on childhood growth.

Main Methods:

  • A cohort of 113 children aged 4-18 years with dyspepsia symptoms was studied.
  • H. pylori infection was diagnosed using the C13 urea breath test.
  • Growth parameters including height, weight, Body Mass Index (BMI), and Standard Deviation Score (SDS) were assessed and compared between infected and non-infected groups.

Main Results:

  • The prevalence of H. pylori infection among the participants was 52.2%.
  • No statistically significant relationship was observed between H. pylori infection and the calculated SDS for height.
  • Similarly, no meaningful association was found between H. pylori infection and the SDS for BMI.

Conclusions:

  • H. pylori infection in children presenting with dyspepsia does not appear to be associated with somatic growth retardation.
  • The findings suggest that H. pylori is unlikely to be a primary cause of growth issues in this pediatric population.
  • Further research may explore other factors influencing growth in children with dyspepsia and H. pylori.

More Related Videos

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...